BrainXell Therapeutics
PrivateLast Round
Grant
Mar 26, 2025
Total Funding Raised
$20.17M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
BrainXell Therapeutics is a biotechnology company that develops autologous, iPSC-derived cell therapies to treat neurodegenerative diseases such as Parkinson's disease and spinal cord injuries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BrainXell Therapeutics Comparables
Compare BrainXell Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kenai Therapeutics | 88% | |
| Aspen Neuroscience | 87% | |
| iRegene Therapeutics | 80% | |
BrainXell Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 26, 2025 | ||||
| Grant | May 1, 2023 | ||||
| Grant | Jan 26, 2023 | ||||
| Series B | Sep 13, 2021 | ||||
| Grant | Nov 1, 2016 |
BrainXell Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Discovery to Product | Grant |
| California Institute for Regenerative Medicine | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors increased 85% MoM.
- Mar 26, 2025
$4M grant from California Institute for Regenerative Medicine
BrainXell Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BrainXell Therapeutics's valuation, stock price, and market status.